As a designated PTEN Center of Excellence, CHOP offers the highest standards in multidisciplinary care.

At our Neuroscience Center, we continually strive to expand our team and bring together specialists from all areas of neuroscience to provide comprehensive and compassionate care for all of our patients and their families. 

Friedreich’s Ataxia is a progressive neurological disorder associated with the loss of the ability to walk, loss of hand coordination and loss of speech.

When getting ready to travel with your family, plan ahead to stay healthy and safe and to be prepared for the unexpected.

Beginning in January 2023, neonatal nurses from Children’s Hospital of Philadelphia (CHOP) will travel to Botswana to help train Botswana nurses in neonatology to improve the health of the country’s smallest citizens.

Researchers at Children’s Hospital of Philadelphia found that targets of cyberbullying were more likely to report suicidal thoughts and attempts, above and beyond offline bullying.

Recently updated developmental milestones should lead to earlier identification of autism and developmental delays.

Four CHOP researchers are part of a world-class research team that will receive $25 million to study solid tumors in children, funded by Cancer Grand Challenges.

The findings, published in the journal Otolaryngology–Head and Neck Surgery, suggest high-dose celecoxib with acetaminophen can be considered an effective alternative to ibuprofen with acetaminophen after tonsillectomy.

New data on show CAR T-cell therapy leads to durable remission and long-term survival in children and young adults with relapsed or refractory B-ALL.